Intravenous Solutions Market (By Product: TPN, PPN; By Nutrients: Vitamins & Minerals, Single-dose Amino Acids) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030

The global intravenous solutions market was valued at US$ 15.9 billion in 2021 is expected to be worth around US$ 28.9 billion by 2030, growing at a registered CAGR of 17.9% during the forecast period 2022 to 2030.

Growth Factors

The growing incidence rate of chronic diseases such as cancer, increase in the number of premature births, and shortage of I.V. solutions in the U.S. are some of the key factors expected to drive the market.

One of the prime areas wherein intravenous (IV) fluids find usage is severe dehydration. Severe dehydration is seen in diseases such as diarrhea, resulting in the depletion of fluids from the body. According to the WHO, in 2017, diarrhea was the second leading cause of death in children under 5 years of age with around 5,25,000 lives lost each year. Intravenous (IV) fluids can play a key role in the treatment and prevention of deaths caused due to the dehydration/fluid loss associated with diarrhea. Other cases where intravenous fluids find application include surgeries and emergency situations.

The ongoing COVID-19 pandemic is expected to have a positive impact on the market. Intensive Care Units (ICU) worldwide are either operating at full capacity or are overcrowded due to the high influx of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As per an article published by BBC, in January 2021, critical care wards across England were running in full capacity. Nutritional care is one of the essential elements in managing these patients. This has increased the demand for intravenous (IV) fluids, as many of the patients, especially the elderly population are placed on ventilators and are unable to consume food orally.

Product Insights

The total parenteral nutrition (TPN) segment held the largest revenue share of 67% in 2021. This segment is also anticipated to register the fastest CAGR during the forecast year. This is due to the rise in gastrointestinal diseases, such as Ulcerative Colitis (UC) and Crohn’s Disease (CD), in which, patients are unable to absorb essential nutrients and thus, these essential nutrients are delivered through an intravenous route. The growth can also be attributed to a rise in the geriatric population, where the patients require feeding essential nutritional products through intravenous routes.

On the basis of products, the market has been segmented into total parenteral nutrition and peripheral parenteral nutrition. Peripheral parental nutrition accounted for a steady CAGR during the forecast year. The peripheral parental nutrition method is used when patients cannot ingest an adequate amount of food but can tolerate some amount of oral feeding. It is administered through a hep-lock, also called a peripheral intravenous line, and is supplemented for a short duration, and its peripheral access is relatively easy to establish. The main driver of this segment is the rise in malnutrition across the world population, which requires a sufficient amount of essential nutrients to maintain health.

Nutrients Insights

On the basis of nutrients, the global market has been further categorized into carbohydrates, single-dose amino acid solution, vitamins & minerals (salt and electrolyte), parenteral lipid emulsion, and others. The single-dose amino acid solution segment held the largest revenue share of 33% in 2021. The growth characteristics of this market are that when a patient’s metabolic requirements for protein are considerably augmented due to extensive burns, gastrointestinal absorption of protein is damaged, andthe alimentary tract can’t be used in such situations, a single-dose amino acid solution is given to the patient.

Also, single-dose amino acids in combination with vitamins, dextrose, and trace elements are administered to undernourished individuals.The vitamins & minerals (salt and electrolyte) segment is estimated to register the fastest CAGR during the forecast period. This is due to malnutrition as people suffering from this usually have a mineral deficiency, which leads to weak bones, immune systems, and fatigue.  It is also used for the treatment of various diseases, such as beriberi, anemia, chronic mental conditions, and pellagra. Based on nutrients, the market has been segmented into carbohydrates, vitamins & minerals, single-dose amino acids, parenteral lipid emulsion, and others. The others segment includes iron, cobalt (in the form of vitamin B12), zinc, and iodine.

Regional Insights

On the basis of geographies, the global market has been categorized into North America, Asia Pacific, Middle East & Africa, Latin America, and Europe. North America dominated the global market in 2021 and accounted for the maximum share of more than 41% of the overall revenue in the same year. This is due to a rise in the geriatric population that leads to increased demand for intravenous solutions, the increasing prevalence of chronic diseases, and the industry’s expansion to fulfill the rising demands due to the flu and coronavirus pandemic. The AsiaPacific region is anticipated to register the fastest CAGR during the forecast period.

The high growth of this region can be attributed to the presence of high expenditure by public as well as private entities in the research sector along with technological advancements and the increasing number of collaborations between various stakeholders, including the medical fraternity, universities, and others. In addition, the increasing prevalence of chronic diseases due to unhealthy food consumption tendencies and the rising demand for cost-effective care treatment are among the key factors that are expected to propel the market growth in the Asia Pacific region.

Key Players

  • Hospira

  • Terumo Corporation

  • B. Braun Melsungen AG

  • Fresenius Kabi

  • Baxter

Market Segmentation

  • Type Outlook

    • Total Parenteral Nutrition (TPN)

    • Peripheral Parenteral Nutrition (PPN)

  • Nutrients Outlook 

    • Carbohydrates

    • Single Dose Amino Acid Solution

    • Vitamins & Minerals (Salt and electrolyte)

    • Parenteral Lipid Emulsion

    • Others

  • Regional Outlook 

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Russia

      • Switzerland

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa

      • South Africa

The Intravenous Solutions market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Intravenous Solutions market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Intravenous Solutions market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Intravenous Solutions market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Intravenous Solutions market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Intravenous Solutions capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Intravenous Solutions by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Intravenous Solutions market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Intravenous Solutions market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Intravenous Solutions market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Intravenous Solutions industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The Intravenous Solutions market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Intravenous Solutions market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Intravenous Solutions market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Intravenous Solutions market. These factors have benefited the growth of the global market for Intravenous Solutions. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Intravenous Solutions. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Intravenous Solutions are as follows:

  • Historic Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

To strategically profile the key players and comprehensively analyze their growth strategies.

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Intravenous Solutions Market, By Type

7.1.  Intravenous Solutions Market, By Type, 2020-2027

7.1.1.    Total Parenteral Nutrition (TPN)

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Peripheral Parenteral Nutrition (PPN)

7.1.2.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Intravenous Solutions Market, By Nutrients

8.1.  Intravenous Solutions Market, By Nutrients, 2020-2027

8.1.1.    Carbohydrates

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Single Dose Amino Acid Solution

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Vitamins & Minerals (Salt and electrolyte)

8.1.3.1.        Market Revenue and Forecast (2016-2027)

8.1.4.    Parenteral Lipid Emulsion

8.1.4.1.        Market Revenue and Forecast (2016-2027)

8.1.5.    Others

8.1.5.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global Intravenous Solutions Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, By Type (2016-2027)

9.1.2.    Market Revenue and Forecast, By Nutrients (2016-2027)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, By Type (2016-2027)

9.1.3.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, By Type (2016-2027)

9.1.4.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, By Type (2016-2027)

9.2.2.    Market Revenue and Forecast, By Nutrients (2016-2027)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, By Type (2016-2027)

9.2.3.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, By Type (2016-2027)

9.2.4.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, By Type (2016-2027)

9.2.5.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, By Type (2016-2027)

9.2.6.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, By Type (2016-2027)

9.3.2.    Market Revenue and Forecast, By Nutrients (2016-2027)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, By Type (2016-2027)

9.3.3.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, By Type (2016-2027)

9.3.4.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, By Type (2016-2027)

9.3.5.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, By Type (2016-2027)

9.3.6.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, By Type (2016-2027)

9.4.2.    Market Revenue and Forecast, By Nutrients (2016-2027)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, By Type (2016-2027)

9.4.3.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, By Type (2016-2027)

9.4.4.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, By Type (2016-2027)

9.4.5.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, By Type (2016-2027)

9.4.6.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, By Type (2016-2027)

9.5.2.    Market Revenue and Forecast, By Nutrients (2016-2027)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, By Type (2016-2027)

9.5.3.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, By Type (2016-2027)

9.5.4.2.        Market Revenue and Forecast, By Nutrients (2016-2027)

Chapter 10.  Company Profiles

10.1.              Hospira

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Terumo Corporation

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              B. Braun Melsungen AG

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Fresenius Kabi

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Baxter

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

12.2.              Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers